Invivyd (IVVD) Other Operating Expenses (2021 - 2026)
Invivyd's (IVVD) quarterly Other Operating Expenses came in at $1.1 million in Q4 2025, up 57.46% YoY from $724000.0 in Q4 2024, and up 4.78% on a QoQ basis from $1.1 million in Q3 2025.
Invivyd (IVVD) Other Operating Expenses (2021 - 2026) Analysis & Trends
Invivyd (IVVD) has 5 years of Other Operating Expenses data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Other Operating Expenses rose 57.46% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.7 million (up 131.58% YoY) and the FY2025 annual result came in at $3.7 million, up 131.58% from the prior year.
- Other Operating Expenses improved to $1.1 million in Q4 2025, from $1.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $17.8 million in Q4 2022 to a low of -$600000.0 in Q4 2023.
- A 5-year average of $2.5 million and a median of $917000.0 in 2021 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2023 — Other Operating Expenses tumbled 103.38% — and 2025, when it surged 678.41%.
- Tracing IVVD's Other Operating Expenses over 5 years: stood at $4.0 million in 2021, then surged by 344.32% to $17.8 million in 2022, then plunged by 103.38% to -$600000.0 in 2023, then surged by 220.67% to $724000.0 in 2024, then jumped by 57.46% to $1.1 million in 2025.
- The last three Other Operating Expenses figures came in at $1.1 million (Q4 2025), $1.1 million (Q3 2025), and $685000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Invivyd | 212.23 Mn | 52.15 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 685,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Dec 31, 2023 | -600,000.00 |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 17.77 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.00 Mn |